Latest Evidence-based pharmacy in developing countries Stories
They say the real crisis stems from current incentives that reward companies for developing large numbers of new drugs with few clinical advantages over existing ones.
Global Health Progress Amplifies New Report that Outlines Barriers in Securing Access to Medicines in Least Developed Countries Importance of drug patents, public-private partnerships highlighted Washington, DC (PRWEB) October 30, 2010 â€œThere is a public health crisis in the least developed countries.
The United Nations World Health Organization (WHO) issued its first-ever guidance on Friday on how to use more than 240 critical medicines for children under the age of 13.
WASHINGTON, Nov. 6 /PRNewswire-USNewswire/ -- America's Specialty Medicines Companies (ASMC), an informal working group of mid-market and smaller innovator pharmaceutical companies, today expressed concerns about H.R.
A new report on medicines in the U.S.
Prescribing costs increase dramatically when people reach 65, according to a detailed analysis of more than five million patients published in the March issue of the British Journal of Clinical Pharmacology.
GENEVA (Reuters) - The World Health Organization said on Saturday it would examine whether the international drug patent system prevents developing countries from obtaining needed medicines, vaccines and diagnostic tests.
INFORMATION ON every prescribed drug will be published on a nurseled website to help patients keep informed about their treatment. NHS Direct is working in partnership with the Medicines and Healthcare products Regulatory Agency on the project.
- a meat pie that is usually eaten at Christmas in Quebec